当前位置：首页 > 文献互助 > 互助详情

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial复制

用户ii3mJbDuMtag 2小时前 6 10 求助中 帖子自动结束时间: 2026-03-04 20:54:13

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

上一篇：Organocatalyst-controlled stereoselective head-to-tail macrocyclizations

下一篇：A new compact DC model of floating gate memory cells without capacitive coupling coefficients

互助时间线

2026-02-27 20:54:13 [发起求助]

最新发布的求助

A new compact DC model of floating gate memory cells without capacitive coupling coefficients 43分钟前
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial 2小时前
Organocatalyst-controlled stereoselective head-to-tail macrocyclizations 2小时前
Design, synthesis and anti-breast cancer activity evaluation of 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine-based PARP1/ATR dual inhibitors 5小时前
Synthesis of Unsymmetrical Ketones Using Chelation-Controlled Sequential Substitution of N-Triazinylamide/Weinreb Amide by Organometallic Reagents 6小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 6小时前
Fine-Tuning the Active-Site Microenvironment of β-Galactosidase to Enhance the Synthesis Ability of Galactooligosaccharides while Minimizing the Impairment to Transglycosylation Activity 6小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 6小时前
† Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production 6小时前
Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation 6小时前
Emerging Medical Therapies for Primary Aldosteronism 6小时前
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com